首页|期刊导航|中华医学杂志（英文版）|Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1:interim analysis of the randomized,controlled,phase 3,non-inferiority TALENT study

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1:interim analysis of the randomized,controlled,phase 3,non-inferiority TALENT study

Bin Su Yun He Yu-Huang Zheng Ling-Hua Li Jin-Feng Chen Jian-Hua Yu Biao Zhu Min Zhao Yong-Tao Sun Wen-Hui Lun Wei Xia Cheng Yao Li-Jun Sun Li-Li Dai Tai-Yi Jiang Mei-Xia Wang Qing-Shan Zheng Hai-Yan Peng Yao Wang Rong-Jian Lu Jian-Hua Hu Hui Xing Qing-Xia Zhao Yi-Ming Shao Dong Xie Tong Zhang Fu-Jie Zhang Hao Wu Wei-Ping Cai Min Wang Hong-Zhou Lu Yuan-Yuan Chen Li Liu Hui Wang

中华医学杂志（英文版）2020，Vol.133Issue(24)：2919-2927,9.

中华医学杂志（英文版）2020，Vol.133Issue(24)：2919-2927,9.DOI:10.1097/CM9.0000000000001273

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1:interim analysis of the randomized,controlled,phase 3,non-inferiority TALENT study

Bin Su ¹Yun He ²Yu-Huang Zheng ³Ling-Hua Li ⁴Jin-Feng Chen ⁴Jian-Hua Yu ⁵Biao Zhu ⁶Min Zhao ⁷Yong-Tao Sun ⁸Wen-Hui Lun ⁹Wei Xia ¹Cheng Yao ¹⁰Li-Jun Sun ¹Li-Li Dai ¹Tai-Yi Jiang ¹Mei-Xia Wang ¹Qing-Shan Zheng ¹¹Hai-Yan Peng ¹²Yao Wang ¹²Rong-Jian Lu ¹⁰Jian-Hua Hu ¹⁰Hui Xing ¹³Qing-Xia Zhao ¹⁴Yi-Ming Shao ¹³Dong Xie ¹⁰Tong Zhang ¹Fu-Jie Zhang ⁹Hao Wu ¹Wei-Ping Cai ⁴Min Wang ¹⁵Hong-Zhou Lu ¹⁶Yuan-Yuan Chen ¹⁴Li Liu ¹⁶Hui Wang²

作者信息

1. Center for Infectious Diseases,Beijing Youan Hospital,Capital Medical University,Beijing 100069,China
2. Department of Infectious Diseases,National Clinical Center for Infectious Diseases,Shenzhen Third People's Hospital,Shenzhen,Guangdong 518112,China
3. Department of Infectious Diseases,The Second Xiangya Hospital,Central South University,Changsha,Hunan 410011,China
4. Infectious Disease Center,Guangzhou Eighth People's Hospital,Guangzhou Medical University,Guangzhou,Guangdong 510060,China
5. Department of Infectious Diseases,Xixi Hospital of Hangzhou,Hangzhou,Zhejiang 310023,China
6. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,The First Affiliated Hospital,Zhejiang University,Hangzhou,Zhejiang 310003,China
7. National Clinical Research Center for Infectious Diseases,the Fifth Medical Center of PLA General Hospital,Beijing 100039,China
8. Department of Infectious Diseases,Tangdu Hospital,The Fourth Military Medical University,Xi'an,Shaanxi 710038,China
9. Clinical and Research Center of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China
10. Frontier Biotechnologies Inc.,Nanjing,Jiangsu 211122,China
11. Center for Drug Clinical Research,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
12. Beijing Co-CRO Medical Development Co.,Ltd.,Beijing 100711,China
13. State Key Laboratory for Infectious Disease Prevention and Control,National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China
14. Department of Infectious Diseases,Infectious Disease Hospital of Henan Province,Zhengzhou,Henan 450061,China
15. Institute of HIV/AIDS,The First Hospital of Changsha,Changsha,Hunan 410005,China
16. Department of Infectious Diseases,Shanghai Public Health Clinical Center,Fudan University,Shanghai 201508,China
折叠

摘要

关键词

HIV/Fusion inhibitor/Albuvirtide/LPV/r/Phase 3 clinical trial

Key words

HIV/Fusion inhibitor/Albuvirtide/LPV/r/Phase 3 clinical trial

引用本文复制引用

Bin Su,Yun He,Yu-Huang Zheng,Ling-Hua Li,Jin-Feng Chen,Jian-Hua Yu,Biao Zhu,Min Zhao,Yong-Tao Sun,Wen-Hui Lun,Wei Xia,Cheng Yao,Li-Jun Sun,Li-Li Dai,Tai-Yi Jiang,Mei-Xia Wang,Qing-Shan Zheng,Hai-Yan Peng,Yao Wang,Rong-Jian Lu,Jian-Hua Hu,Hui Xing,Qing-Xia Zhao,Yi-Ming Shao,Dong Xie,Tong Zhang,Fu-Jie Zhang,Hao Wu,Wei-Ping Cai,Min Wang,Hong-Zhou Lu,Yuan-Yuan Chen,Li Liu,Hui Wang..Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1:interim analysis of the randomized,controlled,phase 3,non-inferiority TALENT study[J].中华医学杂志（英文版）,2020,133(24):2919-2927,9.

基金项目

This work was supported by the Frontier Biotechnologies Inc.,Ministry of Science and Technology of China(Nos.2013ZX09101001 and 2017ZX09201007),the Beijing Municipal of Science and Technology Major Project(Nos.D141100000314005,D141100000314002,and D161100000416003),the National Natural Science Foundation of China(Nos.81772165,81974303,and 81571973),and Beijing Key Laboratory for HIV/AIDS Research(No.BZ0089). （Nos.2013ZX09101001 and 2017ZX09201007）

中华医学杂志（英文版）

OACSCDCSTPCD

ISSN：0366-6999

访问量0

下载量0

段落导航